Background: Understanding the impact of infection-induced immunity on SARS-CoV-2 transmission will provide insight into the transition of SARS-CoV-2 to endemicity. Here we estimate the effects of prior infection induced immunity and children on SARS-CoV-2 transmission in households. Methods: We conducted a household cohort study between March 2020-June 2022 in Managua, Nicaragua where when one household member tests positive for SARS-CoV-2, household members are closely monitored for SARS-CoV-2 infection. Using a pairwise survival model, we estimate the association of infection period, age, symptoms, and infection-induced immunity with secondary attack risk. Results: Overall transmission occurred in 72.4% of households, 42% of household contacts were infected and the secondary attack risk was 13.0% (95% CI: 11.7, 14.6). Prior immunity did not impact the probability of transmitting SARS-CoV-2. However, participants with pre-existing infection-induced immunity were half as likely to be infected compared to naïve individuals (RR 0.53, 95% CI: 0.39, 0.72), but this reduction was not observed in children. Likewise, symptomatic infected individuals were more likely to transmit (RR 24.4, 95% CI: 7.8, 76.1); however, symptom presentation was not associated with infectivity of young children. Young children were less likely to transmit SARS-CoV-2 than adults. During the omicron era, infection-induced immunity remained protective against infection. Conclusions: Infection-induced immunity is associated with protection against infection for adults and adolescents. While young children are less infectious, prior infection and asymptomatic presentation did not reduce their infectivity as was seen in adults. As SARS-CoV-2 transitions to endemicity, children may become more important in transmission dynamics. Article summary: Infection-induced immunity protects against SARS-CoV-2 infection for adolescents and adults; however, there was no protection in children. Prior immunity in an infected individual did not impact the probability they will spread SARS-CoV-2 in a household setting.
Background: Understanding the impact of infection-induced immunity on SARS-CoV-2 transmission will provide insight into the transition of SARS-CoV-2 to endemicity. Here we estimate the effects of prior infection induced immunity and children on SARS-CoV-2 transmission in households. Methods: We conducted a household cohort study between March 2020-June 2022 in Managua, Nicaragua where when one household member tests positive for SARS-CoV-2, household members are closely monitored for SARS-CoV-2 infection. Using a pairwise survival model, we estimate the association of infection period, age, symptoms, and infection-induced immunity with secondary attack risk. Results: Overall transmission occurred in 72.4% of households, 42% of household contacts were infected and the secondary attack risk was 13.0% (95% CI: 11.7, 14.6). Prior immunity did not impact the probability of transmitting SARS-CoV-2. However, participants with pre-existing infection-induced immunity were half as likely to be infected compared to naïve individuals (RR 0.53, 95% CI: 0.39, 0.72), but this reduction was not observed in children. Likewise, symptomatic infected individuals were more likely to transmit (RR 24.4, 95% CI: 7.8, 76.1); however, symptom presentation was not associated with infectivity of young children. Young children were less likely to transmit SARS-CoV-2 than adults. During the omicron era, infection-induced immunity remained protective against infection. Conclusions: Infection-induced immunity is associated with protection against infection for adults and adolescents. While young children are less infectious, prior infection and asymptomatic presentation did not reduce their infectivity as was seen in adults. As SARS-CoV-2 transitions to endemicity, children may become more important in transmission dynamics. Article summary: Infection-induced immunity protects against SARS-CoV-2 infection for adolescents and adults; however, there was no protection in children. Prior immunity in an infected individual did not impact the probability they will spread SARS-CoV-2 in a household setting.
Authors: Jieun Kim; Young June Choe; Jin Lee; Young Joon Park; Ok Park; Mi Seon Han; Jong-Hyun Kim; Eun Hwa Choi Journal: Arch Dis Child Date: 2020-08-07 Impact factor: 3.791
Authors: Yanshan Zhu; Conor J Bloxham; Katina D Hulme; Jane E Sinclair; Zhen Wei Marcus Tong; Lauren E Steele; Ellesandra C Noye; Jiahai Lu; Yao Xia; Keng Yih Chew; Janessa Pickering; Charles Gilks; Asha C Bowen; Kirsty R Short Journal: Clin Infect Dis Date: 2021-06-15 Impact factor: 9.079
Authors: Sami Almudarra; Shady Kamel; Eman Saleh; Rehab Alaswad; Amaal Alruwaily; Shaza Almowald; Ada Mohammed Alqunaibet; Abdullah Almudiaheem; Hind Almutlaq; Haleema Alserehi; Safar Almalki; Mohannad Abdulhafiz Bahlaq; Abdullah Jaber Alsahafi; Faisal Alsaif; Abdullah T Khojah; Jaffar A Al-Tawfiq; Sari Ibrahim Asiri; Abdullah Assiri; Hani Jokhdar Journal: Infection Date: 2021-12-08 Impact factor: 7.455
Authors: Sarah L Silverberg; Bei Yuan Zhang; Shu Nan Jessica Li; Conrad Burgert; Hennady P Shulha; Vanessa Kitchin; Laura Sauvé; Manish Sadarangani Journal: BMC Pediatr Date: 2022-04-02 Impact factor: 2.125
Authors: Victoria Hall; Sarah Foulkes; Ferdinando Insalata; Peter Kirwan; Ayoub Saei; Ana Atti; Edgar Wellington; Jameel Khawam; Katie Munro; Michelle Cole; Caio Tranquillini; Andrew Taylor-Kerr; Nipunadi Hettiarachchi; Davina Calbraith; Noshin Sajedi; Iain Milligan; Yrene Themistocleous; Diane Corrigan; Lisa Cromey; Lesley Price; Sally Stewart; Elen de Lacy; Chris Norman; Ezra Linley; Ashley D Otter; Amanda Semper; Jacqueline Hewson; Silvia D'Arcangelo; Meera Chand; Colin S Brown; Tim Brooks; Jasmin Islam; Andre Charlett; Susan Hopkins Journal: N Engl J Med Date: 2022-02-16 Impact factor: 91.245